PDE inhibitors could be useful in the treatment of asthma because of their bronchodilator and/or anti-inflammatory activities. Recently, some selective PDE3, PDE4 and PDE3/4 inhibitors have been shown to have beneficial effects in patients with asthma suggesting that such drugs may offer novel therapeutic options for the treatment of this disease.
Matera, M., Page, C., Cazzola, M. (2014). PDE inhibitors currently in early clinical trials for the treatment of asthma. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 23(9), 1267-1275 [10.1517/13543784.2014.921157].
PDE inhibitors currently in early clinical trials for the treatment of asthma
CAZZOLA, MARIO
2014-09-01
Abstract
PDE inhibitors could be useful in the treatment of asthma because of their bronchodilator and/or anti-inflammatory activities. Recently, some selective PDE3, PDE4 and PDE3/4 inhibitors have been shown to have beneficial effects in patients with asthma suggesting that such drugs may offer novel therapeutic options for the treatment of this disease.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
